1. Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development

   • Geok Choo Sim
   • Jessica Chacon
   • Laszlo Radvanyi

   Review Article 03 June 2014 Pages: 421 - 437

   

2. Similar Names for Similar Biologics

   • Nicole Casadevall
   • Thomas Felix
   • David G. Warnock

   Current Opinion 08 July 2014 Pages: 439 - 444

3. Optimisation of Omalizumab Dosage in Patients with Severe Persistent Allergic Asthma Using recoveryELISA

   • Jens-Oliver Steiß
   • G. Becher

   Original Research Article 05 June 2014 Pages: 445 - 450

   

4. Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin^®)

   • Susan Hurst
   • Anne M. Ryan
   • Teresa A. Smolarek

   Original Research Article Open access 08 July 2014 Pages: 451 - 459

   

5. Making Choices: Health Consumers, Regulation and the Global Stem Cell Therapy Market

   • Brian Salter
   • Yinhua Zhou
   • Saheli Datta

   Commentary 01 July 2014 Pages: 461 - 464

6. Elosulfase Alfa: A Review of Its Use in Patients with Mucopolysaccharidosis Type IVA (Morquio A Syndrome)

   • Katherine A. Lyseng-Williamson

   Adis Drug Evaluation 09 September 2014 Pages: 465 - 475